318000.KQ Korea Bio-Gen Co.Ltd

Basic Materials Chemicals KOSDAQ
2,390 KRW
Close of Nov 1, 2026
2,360 5,348
Market cap
KRW 20.8B
P/E
13.4x
P/B
0.44x
ROE
2.5%
Dividend yield
3.14%
Fundamental score
1.8/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 318000.KQ undervalued?

Graham number
Price2,390
Graham value4,651
Discount48.6%

318000.KQ trades 48.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Korea Bio-Gen Co.Ltd fundamental analysis

9 of 22 checks passed

ROE 0/2

Low return on equity (2.5%), below 10%.

ROA 0/1

Return on assets (2.2%) is below the industry median (4.7%).

Profit Consistency 2/2

Profitable for 6 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-31.2%) is not above the 5-year average (-5.1% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-31.2%) is below the industry median (-16.9%).

Revenue Growth 0/2

Revenue shrank 0.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 174.6x against interest expense, well covered.

PE vs Market 0/1

PE (13.4x) is above the market median (11.3x).

PE vs Industry 0/1

PE (13.4x) is above the industry median (9.1x).

PBV 1/1

Price to book (0.4x) is below the industry median (0.6x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 5.9, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (3.1%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 25.2%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Korea Bio-Gen Co.Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Korea Bio-Gen Co.Ltd

KBG Corp. produces and supplies a range of fine chemicals in South Korea and internationally. The company offers silicone chemicals, such as functional organosilanes, functional silicone polymers, silicone resins and intermediates, silicone pressure sensitive adhesives, and silicone materials for electronics; specialty chemicals, including polymerization inhibitors; and food additives, as well as silicon inorganic chemical materials, organic materials, bio-materials, and oth…

Full company profile